ICM
BIIB icon

Islay Capital Management’s Biogen BIIB Stock Holding History

Islay Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-466
Closed -$130K – 282
2021
Q1 		$130K Buy
466
+132
+40% +$35.6K 0.11% 126
2020
Q4 		$82K Hold
334
– – 0.07% 147
2020
Q3 		$95K Buy
334
+86
+35% +$24K 0.1% 110
2020
Q2 		$66K Sell
248
-135
-35% -$40.6K 0.08% 151
2020
Q1 		$121K Buy
383
+62
+19% +$18.8K 0.16% 79
2019
Q4 		$95K Buy
+321
New +$89.1K 0.09% 104

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Islay Capital Management's BIIB Position: Q2 2021 in Review

Islay Capital Management sold out of Biogen (BIIB) in Q2 2021, closing a stake of 466 shares — an estimated $130K sold.

Islay Capital Management first reported a position in BIIB in Q4 2019 and held it in 6 quarters. The position peaked at $130K in Q1 2021. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Islay Capital Management reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Islay Capital Management sold 466 Biogen shares in Q2 2021, an estimated $130K.
  • Islay Capital Management first reported a position in Biogen in Q4 2019 and held it in 6 quarters.
  • Islay Capital Management's Biogen position peaked at $130K in Q1 2021.
  • 1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Islay Capital Management's 13F filing for Q2 2021, filed 2 Aug 2021.